Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
10/2003
10/16/2003WO2003037250A3 Matrix methods for analyzing properties of botanical samples
10/16/2003WO2003035904A3 Methods and compositions to evaluate antibody treatment response
10/16/2003WO2003035825A3 Photovoltaic device to accelerate the interaction among biomolecules
10/16/2003WO2003035239A3 Resin dispensing device
10/16/2003WO2003034819A3 Nox software sensor
10/16/2003WO2003034069A3 Tcmp 03 protein for use in cancer therapy
10/16/2003WO2003033660A3 9136, a human aldehyde dehydrogenase family member and uses therefor
10/16/2003WO2003033650A3 Recombinant renilla reniformis system for bioluminescence resonance energy transfer
10/16/2003WO2003029426A3 Human and murine cytokine polypeptides
10/16/2003WO2003029413A3 A novel g protein-coupled receptor, gave 10
10/16/2003WO2003027639A3 Glucocorticoid receptor nuclear translocation domain
10/16/2003WO2003027309A3 Diagnostic probe detection system
10/16/2003WO2003027250A3 Monoclonal antibodies to the drug tilmicosin and a method for detecting the same
10/16/2003WO2003026562A3 A crytallized complex of an eubacterium large ribosome subunit bound to an antibiotic
10/16/2003WO2003025540A3 Differential tagging of polymers for high resolution linear analysis
10/16/2003WO2003025224A3 Differential gene expression in schizophrenia
10/16/2003WO2003024993A3 Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using elisa assays
10/16/2003WO2003022999A3 Rapid detection of replicating cells
10/16/2003WO2003021251A9 Methods for characterization of polymers using multi-dimentional liquid chromatography
10/16/2003WO2003018609A3 Application of peptide conjugates to alzheimer's disease
10/16/2003WO2003016488A3 Cell separation system
10/16/2003WO2003014733A3 Methods and markers for identifying activated synapses
10/16/2003WO2003014730A3 Method and apparatus for testing flexibility of woven wire-cloth
10/16/2003WO2003014359A3 A fusion protein
10/16/2003WO2003014077A3 Crystal forms and mutants of rank ligand
10/16/2003WO2003012127A3 Assay for identifying inhibitors of hiv rt dimerization
10/16/2003WO2003012047A3 Isolation of membrane bound ligand-specific complexes
10/16/2003WO2003012042A3 Ratio-based oligonucleotide probe selection
10/16/2003WO2003012034A3 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
10/16/2003WO2003008551A3 Systems and methods for predicting active site residues in a protein
10/16/2003WO2003007685A3 Detecting and treating reproductive tract disorders
10/16/2003WO2003005450A9 Nanoscale wires and related devices
10/16/2003WO2003005036A3 Epf receptor assays, compounds and therapeutic compositions
10/16/2003WO2003004520A3 Mycobacterial antigens expressed during latency
10/16/2003WO2003002716A3 Polymer stabilized proteinases
10/16/2003WO2003002709A3 Novel technology for genetic mapping
10/16/2003WO2002101355A9 Improved proteomic analysis
10/16/2003WO2002101018A3 Methods for inducing reversible stasis
10/16/2003WO2002100896A3 Method for diagnosing cancer susceptibility
10/16/2003WO2002099121A3 Toxicity monitor
10/16/2003WO2002099043A3 P5CRS AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
10/16/2003WO2002098899A3 CHDs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
10/16/2003WO2002097043A3 Wnv core protein/capsid interacting protein and uses of the same
10/16/2003WO2002093176A3 Methods for identifying compounds for treatment of ibd
10/16/2003WO2002088665A3 Methods for identifying drugs specific for known molecular targets using model compounds specific for the molecular targets
10/16/2003WO2002086512A3 Haemoglobin assay
10/16/2003WO2002086157A3 Use of semaphorin 3a for diagnosing and treating cancer, especially prostate cancer
10/16/2003WO2002084298A3 Medicaments which are modulators of hm74 and/or hm74a activity
10/16/2003WO2002079488A3 Oligonucleotide microchips to detect protein-nucleic acid interactions
10/16/2003WO2002079428A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
10/16/2003WO2002077643A3 Detection of inflammations
10/16/2003WO2002077211A3 A virus (cryptovirus) within the rubulavirus genus and uses therefor
10/16/2003WO2002072868A3 Methods and tools for nucleic acid sequence analysis selection and generation
10/16/2003WO2002070655A3 Mouse cytokine receptor
10/16/2003WO2002068956A3 Method for determining pharmaceutically active substances
10/16/2003WO2002068680A3 Compositions and methods for regulating endogenous inhibitor of atp synthase, including treatment for diabetes
10/16/2003WO2002068677A8 Novel methods of diagnosis of metastatic colorectal cancer, compositions and methods of screening for modulators of metastatic colorectal cancer
10/16/2003WO2002068675A3 Product, method and system for identifying collagenase-cleaved type ii collagen
10/16/2003WO2002065124A3 Improved method for detecting cells
10/16/2003WO2002064816A3 Multiple determinants for metabolic phenotypes
10/16/2003WO2002063305A3 Hemorphins as endogenous ligands for human g-protein coupled bombesin receptor subtype 3 (brs-3)
10/16/2003WO2002062821A8 Peptide or protein microassay method and apparatus
10/16/2003WO2002061392A3 Method and apparatus for the confinement of materials in a micromachined chemical sensor array
10/16/2003WO2002061089A3 Crystallized hnf4 gamma ligand binding domain polypeptide and screening methods employing same
10/16/2003WO2002060930A3 Method for the identification of extracellular domains of the epstein barr virus (ebv), tumor-associated latent membrane proteins and for the selection of antibody reagents reactive therewith
10/16/2003WO2002059606A3 Targets and therapeutic agents for the treatmnt of epstein-barr virus infection
10/16/2003WO2002057430A3 Pluripotent adult stem cells derived from regenerative tissue
10/16/2003WO2002057313A3 Receptor-binding compounds and methods for identifying them
10/16/2003WO2002054064A3 Method for screening for progesterone receptor isoform-specific ligands
10/16/2003WO2002044384A3 T-cell epitope of the papillomavirus l1 and e7 protein and use thereof in diagnostics and therapy
10/16/2003WO2002031509A3 Method for determining mass altering moiety in peptides
10/16/2003WO2002029098A3 Genetic factors affecting the outcome of viral infections
10/16/2003WO2002018631A3 Diagnosis of illnesses or predisposition to certain illnesses
10/16/2003WO2002004680A3 Real-time sequence determination
10/16/2003WO2001088148A3 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
10/16/2003US20030196212 An isolated nucleic acid sequence encoding a polypeptide specific bind to the receptor; treating infertility, contraception disorders, sexual dysfunction, nervous system disorders, psychiatric disorders, liver disorders
10/16/2003US20030195770 Medical data processing system
10/16/2003US20030195708 Method for analyzing an unknown material as a blend of known materials calculated so as to match certain analytical data and predicting properties of the unknown based on the calculated blend
10/16/2003US20030195707 Methods of dna marker-based genetic analysis using estimated haplotype frequencies and uses thereof
10/16/2003US20030195706 Method for classifying genetic data
10/16/2003US20030195454 Access disconnection systems and methods
10/16/2003US20030195452 Hematocrit sampling system
10/16/2003US20030195431 Observation of effects of body fluids on indicator cells for disease diagnosis
10/16/2003US20030195350 Administering a probe substrate, detecting metabolites in a biological sample, determining metabolic phenotype of each individual
10/16/2003US20030195349 H. pylori flbA polypeptides, immunogenic and vaccinating compositions comprising H. pylori flbA polypeptides, and compositions for detection of an infection comprising H. pylori flbA polypeptides
10/16/2003US20030195347 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/16/2003US20030195345 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/16/2003US20030195344 A DNA libraries having the vector sequences for coding the membrane receptor proteins, or fusion proteins, for binding the membrane-bound proteins; drug delivery target to specific cell site
10/16/2003US20030195337 UL16 binding protein 4
10/16/2003US20030195334 Cell culturing and expressing the protein, chimeric polypeptides, fusion proteins; membrane protein receptor is used to bind the protein drugs thrombolytic agents, interferons, interleukins, erythropoietins
10/16/2003US20030195333 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/16/2003US20030195222 Substituted pyrimidinones and pyrimidinthiones
10/16/2003US20030195153 Comprises metalloproteinase (stromelysin) inhibitors
10/16/2003US20030195148 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/16/2003US20030195147 Identification of molecular structures, especially peptides, which are capable of acting at either insulin or insulin-like growth factor receptors as agonists or antagonists; treatment of diabetes
10/16/2003US20030195139 For treating subject with abstinence syndrome due to nicotine, an opiate, cocaine, an amphetamine, a benzodiazipine and ethanol
10/16/2003US20030195138 BAP-1: methods of assaying for cell-cycle modulators
10/16/2003US20030195106 Devices and methods for using centripetal acceleration to drive fluid movement on a microfluidics platform
10/16/2003US20030194818 Platelet immunoglobulin bead suspension and flow cytometry
10/16/2003US20030194816 Method of collecting chemically contaminating impurity constituents contained in air
1 ... 2485 2486 2487 2488 2489 2490 2491 2492 2493 2494 2495 2496 2497 2498 2499 2500 2501 2502 2503 2504 2505 ... 3937